• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXHB2000011 甲磺酸帕拉德福韦片 pradefovir mesylate Tablet Chemical Drugs Supplementary Application 2020-02-26 西安新通药物研究有限公司 Xi’an Xintong Pharmaceutical Research Co Ltd In Review 2020-02-25 view
CXHL1900328 CE-磷苯妥英钠注射液 fosphenytoin sodium Injection Chemical Drugs(2.2) New Drug Application 2019-11-07 西安新通药物研究有限公司 Xi’an Xintong Pharmaceutical Research Co Ltd In Review 2019-11-06 view
CXHL1900327 CE-磷苯妥英钠注射液 fosphenytoin sodium Injection Chemical Drugs(2.2) New Drug Application 2019-11-07 西安新通药物研究有限公司 Xi’an Xintong Pharmaceutical Research Co Ltd In Review 2019-11-06 view
CXHB1900018 注射用MB07133 MB07133 Lyophilized Chemical Drugs Supplementary Application 2019-03-20 西安新通药物研究有限公司 Xi’an Xintong Pharmaceutical Research Co Ltd In Review 2019-03-19 view
CXHB1900017 MB07133 MB07133 Other Chemical Drugs Supplementary Application 2019-03-20 西安新通药物研究有限公司 Xi’an Xintong Pharmaceutical Research Co Ltd In Review 2019-03-19 view
CXZL1700049 飞天追风片 Tablet Chinese Herbal Medicine(6.1) New Drug Application 2018-10-29 西安新通药物研究有限公司 Xi’an Xintong Pharmaceutical Research Co Ltd In Review 2018-10-26 view
CXHL1800141 富马酸海普诺福韦片 Tablet Chemical Drugs(1) New Drug Application 2018-09-06 西安新通药物研究有限公司 Xi’an Xintong Pharmaceutical Research Co Ltd In Review 2018-09-04 view
CXHL1800140 富马酸海普诺福韦 Injection Chemical Drugs(1) New Drug Application 2018-09-06 西安新通药物研究有限公司 Xi’an Xintong Pharmaceutical Research Co Ltd In Review 2018-09-04 view
CXHL1501734 马来酸阿法替尼 Afatinib Dimaleate Active ingredient Chemical Drugs(3.1) New Drug Application 2015-10-08 西安新通药物研究有限公司 Xi’an Xintong Pharmaceutical Research Co Ltd Certificate Issued 2016-09-03 view
CXHL1501736 马来酸阿法替尼片 Afatinib Dimaleate Tablet Chemical Drugs(3.1) New Drug Application 2015-10-08 西安新通药物研究有限公司 Xi’an Xintong Pharmaceutical Research Co Ltd Certificate Issued 2016-09-03 view
CXHL1501735 马来酸阿法替尼片 Afatinib Dimaleate Tablet Chemical Drugs(3.1) New Drug Application 2015-10-08 西安新通药物研究有限公司 Xi’an Xintong Pharmaceutical Research Co Ltd Certificate Issued 2016-09-03 view
CXHL1501678 醋酸艾司利卡西平片 eslicarbazepine acetate Tablet Chemical Drugs(3.1) New Drug Application 2015-09-23 西安新通药物研究有限公司 Xi’an Xintong Pharmaceutical Research Co Ltd Certificate Issued 2016-09-03 view
CXHL1501677 醋酸艾司利卡西平片 eslicarbazepine acetate Tablet Chemical Drugs(3.1) New Drug Application 2015-09-23 西安新通药物研究有限公司 Xi’an Xintong Pharmaceutical Research Co Ltd Certificate Issued 2016-09-03 view
CXHL1501676 醋酸艾司利卡西平 eslicarbazepine acetate Active ingredient Chemical Drugs(3.1) New Drug Application 2015-09-23 西安新通药物研究有限公司 Xi’an Xintong Pharmaceutical Research Co Ltd Certificate Issued 2016-09-03 view
CXZL1500011 丹鹿健腰颗粒 Granule Chinese Herbal Medicine(6.1) New Drug Application 2015-04-16 西安新通药物研究有限公司 Xi’an Xintong Pharmaceutical Research Co Ltd Certificate Issued 2016-11-09 view
CXHL1500366 卡巴他赛注射液 cabazitaxel Injection Chemical Drugs(3.1) New Drug Application 2015-04-02 西安新通药物研究有限公司 Xi’an Xintong Pharmaceutical Research Co Ltd Certificate Issued 2016-05-31 view
CXHL1500367 卡巴他赛 cabazitaxel Active ingredient Chemical Drugs(3.1) New Drug Application 2015-04-02 西安新通药物研究有限公司 Xi’an Xintong Pharmaceutical Research Co Ltd Certificate Issued 2016-05-31 view
CXZL1400068 仙灵二至颗粒 Granule Chinese Herbal Medicine(6.1) New Drug Application 2014-12-11 西安新通药物研究有限公司 Xi’an Xintong Pharmaceutical Research Co Ltd Certificate Issued 2016-04-18 view
CXHL1401101 福沙匹坦二甲葡胺 fosaprepitant dimeglumine Active ingredient Chemical Drugs(3.1) New Drug Application 2014-10-09 西安新通药物研究有限公司 Xi’an Xintong Pharmaceutical Research Co Ltd Certificate Issued 2016-02-04 view
CXHL1401103 注射用福沙匹坦二甲葡胺 fosaprepitant dimeglumine Lyophilized Chemical Drugs(3.1) New Drug Application 2014-10-09 西安新通药物研究有限公司 Xi’an Xintong Pharmaceutical Research Co Ltd Certificate Issued 2016-02-04 view